On December 9-10, 2023, the 2023 China Traditional Chinese Medicine Industry High Quality Development Conference and the 4th China Traditional Chinese Medicine Brand Building Conference, hosted by the China Association of Traditional Chinese Medicine, were held in Beijing. The theme of this conference is "Brand led Inheritance and Innovation", aiming to assist in the implementation of the Healthy China and Rural Revitalization Strategy, and continuously promote the high-quality development of the traditional Chinese medicine industry. Leaders from competent departments such as the State Administration of Traditional Chinese Medicine, the National Medical Products Administration, the Ministry of Agriculture and Rural Affairs, the National Medical Security Administration, the Ministry of Industry and Information Technology, the National Forestry and Grassland Administration, the National Development and Reform Commission, and the National Health Commission, as well as representatives from sister associations, attended the conference. Experts from think tanks and industry associations of the China Association of Traditional Chinese Medicine, as well as representatives from some local governments, research institutes, and higher education institutions, attended the conference More than 500 member units and individuals from all walks of life participated in the event.

At the main forum, Huang Luqi, chairman of the organizing committee of the conference, academician of the CAE Member, deputy director of the State Administration of Traditional Chinese Medicine, president of the Chinese Academy of Traditional Chinese Medicine, and president of the Chinese Association of Traditional Chinese Medicine, delivered a keynote report on the theme of "Strategic Thinking on Scientific and Technological Innovation in the Chinese Medicine Industry".

Zhao Junning, Deputy Director of the National Medical Products Administration, delivered a keynote speech on the scientific process and regulatory legislation of traditional Chinese medicine regulation in China.

Zhang Min, Chairman of Mengyang Pharmaceutical, participated in this grand event as Vice President of China Association of Traditional Chinese Medicine and was invited to host the 4th China Traditional Chinese Medicine Brand Building Conference. Mengyang Pharmaceutical has become a new member of the "Traditional Chinese Medicine Brand Cluster".

The "Traditional Chinese Medicine Brand Cluster" aims to integrate industry resources, enhance the overall competitiveness of the traditional Chinese medicine industry, and jointly promote the development and innovation of the industry by gathering excellent enterprises and brand products, scientific research institutions, and relevant government departments within the industry.

At the same time, a new session of the Drug Clinical Evaluation Research Professional Committee of the China Association of Traditional Chinese Medicine was held during the conference, and Xu Xiang, the General Manager of Mengyang Pharmaceutical (Shanghai) Co., Ltd., was elected as the Executive Member of the Second Committee of the Drug Clinical Evaluation Research Professional Committee of the China Association of Traditional Chinese Medicine.

Becoming a member of the "Traditional Chinese Medicine Brand Cluster" is a recognition and incentive for Mengyang Pharmaceutical to uphold integrity, innovate, and inherit classics. Mengyang Pharmaceutical will leverage the "Traditional Chinese Medicine Brand Cluster" platform, not only focusing on market demand and quality, but also valuing ecological benefits, further strengthening communication and cooperation with other enterprises and institutions in the industry, and continuously improving its core competitiveness, Together contribute to the sustainable development of the traditional Chinese medicine industry.